Keybanc analyst Todd Thomas downgrades VICI Properties (NYSE:VICI) from Overweight to Sector Weight.
Reunion Neuroscience’s Q4 And Full Year 2023 Financial Results, To Close Take-Private Deal In Q3
Clinical-stage psychedelics firm Reunion Neuroscience Inc. (NASDAQ: REUN) reported fiscal results for the fourth quarter and year ended March 31 plus corporate updates.
Here's a breakdown of the report: